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Edited by Ned ManteiAbstract In the perspective of clinical translation of stem cell
research, it would be advantageous to develop new techniques
to detect donor cells after transplantation to track their fate
and thus better understand their role in regeneration of damaged
and diseased tissues. In this study we use X-ray computed micro-
tomography for three-dimensional visualization of stem cells that
were labeled with magnetic nanoparticles and transplanted via
intra-arterial infusion. We show that X-ray computed microto-
mography oﬀers the possibility to detect with high deﬁnition
and resolution human cells after transplantation, and opens
new possibilities for both experimental stem cell research.
 2006 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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Attempts to repair muscle damage in Duchenne muscular
dystrophy (DMD) by transplanting myogenic progenitors di-
rectly into muscles are hampered by limited cell survival and
the limited migration of donor cells in the muscles. Recent
work supports the idea that stem cells can reach the site of
muscle regeneration though systemic routes and thus contrib-
ute to muscle repair more eﬃciently than canonical myogenic
progenitors [1,2]. We recently identiﬁed a subpopulation of
human circulating stem cells expressing the CD133 antigen
that can participate in muscle regeneration and also replenish
the satellite cell compartment in the injected dystrophic mus-
cles. Moreover, CD133 cells caused a signiﬁcant regeneration
of skeletal muscle structure and function when delivered
intra-arterially to skeletal muscle tissues of scid-mdx mice [1].
Elucidation of the mechanisms involved in muscle homing of
stem cells will improve the eﬃcacy of a potential therapy for
muscular dystrophy based on the systemic delivery of such
stem cells. To this aim, the possibility of detecting donor cells
inside transplanted tissues would be of crucial importance.
Current microscopy techniques such as light, ﬂuorescence,
scanning and transmission electron microscopy are limited to
two-dimensional (2D) local information or otherwise require*Corresponding author. Fax: +39 02 50320430.
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doi:10.1016/j.febslet.2006.09.031laborious three-dimensional (3D) reconstruction of serial sec-
tions. Here, we explore the use of X-ray computed microto-
mography (microCT) as an experimental technique with high
spatial resolution of 1.65 lm for detection of stem cells, previ-
ously labeled with nanoparticles of iron oxide, inside skeletal
muscles of dystrophic mice after intra-arterial transplantation.
This technique also oﬀer the possibility of obtaining a quanti-
ﬁcation of the number of cells that are able to migrate from the
blood stream inside the muscle tissue, and a 3D visualization
of their distribution.2. Materials and methods
2.1. Isolation of human CD133+ cells from the blood
Human blood-derived CD133+ cells were isolated from mononucle-
ated cells collected by centrifugation (Ficoll-Hypaque; Pharmacia Bio-
tech, Uppsala, Sweden) of several buﬀy coats, diluted 1:2 in RPMI
1640 medium (GIBCO, Invitrogen Life Technologies), incubated with
CD133-phycoerythrin (CD133PE Miltenyi Biotech, Bergisch-Glad-
bach, Germany), and sorted to obtain puriﬁed CD133+ cells. After
selection, an aliquot of the CD133+ cell fraction was analyzed for
assessment of purity.
2.2. Self-renewal and pluripotentiality of human blood-derived CD133+
cells
To determine whether circulating CD133+ cells exhibit the stem cell
characteristic of self-renewal, we plated blood-derived CD133+ cells at
a density of 10 cells/cm2, grew them to a density of 50–150 cells per col-
ony, isolated them with cylinders, and transferred them to separate
wells on a mouse embryonic ﬁbroblast feeder layer inactivated by
mitomycin C (10 ng/ml). These conditions promoted the proliferation
of blood-derived CD133+ cells in the presence of RPMI 1640 medium
supplemented with 20% FBS, 2 mM glutamine, 200 U/l penicillin,
200 lg/l streptomycin, and 5 mM HEPES. The activity of clonal
CD133+ cells was monitored in the following in vitro conditions: (i)
for myogenic diﬀerentiation CD133+ cells were cocultured with
C2C12 myoblasts cell line as previously described [1]; (ii) for hemato-
poietic diﬀerentiation CD133+ cells were tested with methylcellulose
culture using a method previously described [3] and the colonies were
stained with May–Grunwald–Giemsa; (iii) for induction of diﬀerentia-
tion into endothelial cells, cloned CD133+ cells were cultured as de-
scribed previously [4] in endothelial growth medium (M199; Gibco
BRL; Invitrogen Life Technologies), placed on 12-well plates coated
with 0.2% gelatine, and stained with primary antibodies against human
VE-cadherin (BD Bioasciences-Immunocytometry Systems) and CD31
(Chemicon International, CA).2.3. Labeling of CD133+ cells with Endorem
Stem cells were labeled with 250 lg/ml nanoparticles of FeO (Endo-
rem) in RPMI 1640 medium enriched with 20 ng/ml epidermal
growth factor (EGF) and 10 ng/ml basic ﬁbroblastic growth factorblished by Elsevier B.V. All rights reserved.
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loid. This is a commercially available contrast agent based on dextran-
coated iron-oxide nanoparticles, and has been approved for human use
[5]. The crystal size varies from 4.3 to 5.6 nm, and the whole particle
size is 150 nm [5]. The mean iron concentration in a 2 ml sample con-
taining 1 million of cells was 88.5 lg/ml, which correspond to an aver-
age value of 177 pg of iron per cell. Cells were visualized as blue spots
after Prussian blue staining and counted [6,7] and viability was evalu-
ated by ﬂow cytometry after double staining with propidium iodide
(PI) and annexin V.
2.4. Magnetic resonance imaging visualization
Magnetic resonance imaging (MRI) was used to study the fate of hu-
man CD133+ stem cells after their intra-arterial delivery into the dys-
trophic scid/mdx mice [1]. 500 · 103 Endorem-positive stem cells were
injected into the femoral artery of 8 scid/mdxmice, and 12 h after graft-
ing the animals were visualized by MRI. Images were obtained using a
4.7-T spectrometer (Burker, Koo Wee Rup, VIC, Australia) equipped
with an in-house made surface coil. Single sagittal, coronal and trans-
versal images were obtained by fast gradient-echo sequence to localize
the subsequent T2-weighted transverse images, as measured by a stan-
dard turbo spin-echo sequence. Sequence parameters used were: repe-
tition time (TR) = 2000 ms, eﬀective echo time (TE) = 42.5 ms, turbo
factor = 4, number of acquisitions (AC) = 16, feld of view
(FOV) = 3.5 cm, matrix 256 · 256, slice thickness 0.5 mm, slice separa-
tion 1 mm. Two sets of interleaved transversal images were measured
to cover the whole muscle. The same muscles monitored by MRI were
isolated, processed by micro-CT and then characterized by immuno-
histochemistry for the expression of CD133 antigen and Prussian blue
staining [6].
2.5. In vivo transplantation
For X-ray micro-CT investigation 1 · 106 labelled CD133+ cells
were injected into the femoral artery of scid/mdx mice (n = 10), a dys-
trophic animal model that allow transplantation of human cells [1]. In
these experiments the reduced ﬁeld of view (up to 2 mm in diameter
and 3 mm long) is compensated by the high resolution of 1.65 lm.
Therefore, to maintain the high resolution we analyzed muscle biopsies
of 2 mm/2 mm/2 mm size. Twenty-four hours after cell transplanta-
tion, the animals were sacriﬁced and Tibialis Anterior (TA) biopsies
were isolated from injected legs and analyzed by microCT. In a second
set of experiments, we evaluated the minimum number of cells that
could be detected by the microCT technique. We analyzed nine biop-
sies of muscles injected with diﬀerent stem cells numbers (500000,
n = 6; 100000, n = 6; and 50000, n = 6) and isolated at three diﬀerent
times (2, 12 and 24 h) after injection. Furthermore, freshly isolated
CD133+ cells (1 · 106) were injected into the right femoral artery of
a control group of animals (n = 3) in order to demonstrate that unla-
beled cells were not detectable with micro-CT. To demonstrate the
speciﬁcity of our method 200 ll of a saline buﬀer solution (PBS) en-
riched with nanoparticles without cells (88.5 lg/ml) were also injected
directly into the femoral artery of scid/mdx mice as control group
(n = 4). Another group of control was represented by scid/mdxmice in-
jected with Endorem labeled human ﬁbroblast cells which are not
able to migrate through the vessels (n = 5).
2.6. X-ray computed microtomography image acquisition
A micro-CT system [European Synchrotron Radiation Facility
(ESRF) Grenoble, France] was used to non-destructively image and
quantify the 3D microstructural morphology and anisotropy of each
sample. MicroCT experiments were performed with a monochromatic
beam and a sample-to-detector distance of 15 mm. Several preliminary
experiments were performed, varying the X-ray energy values between
18 and 27 keV in order to obtain optimal conditions for the X-ray
absorption contrast among the diﬀerent phases contained in samples
under investigation. The acquisition setup was based on previously de-
scribed [7,8] 3D parallel tomography. 1000 projections were obtained
from each sample over 180 with an exposure time of 1 s per projec-
tion. Gadox scintillator associated to a FReLoN 2048 · 2048 pixel
CCD camera was used as a detector, with the pixel size set to
1.65 lm, yielding a ﬁeld of view of about 3 mm. Isotropic slice data
were obtained and reconstructed into 2D images. The total radiation
dose for a sample during the synchrotron imaging sequence is limited
to 0.2 Gy.2.7. Image reconstruction
3D reconstruction of the samples was obtained from the series of 2D
projections using a 3D ﬁltered back projection algorithm implemented
at ESRF. Furthermore, diﬀerent grey phases were coloured using 3D
display software in order to make them more easily recognizable. A
volume of about (800)3 voxels was reconstructed for each sample,
yielding a cube with a 4.91 lm size in the three directions of space.
The reconstructed values corresponding to the linear attenuation coef-
ﬁcient for the employed X-ray energy ranged between 0 and 9 cm1,
and were distributed in 256 image grey levels.
2.8. Three-dimensional visualization
Volume rendering is a 3D visualization method by which the data
volume is rendered directly without decomposing it into geometric
primitives. A 2 GHz Pentium PC with 1 Gb RAM and commercial
software VGStudio MAX 1.1 were used to generate 3D images and
to visualize the distribution of phases in 3D. In order to achieve opti-
mal settings for the image quality, we used Scatter HQ algorithm with
an over sampling factor of 5.0 and activated color rendering.
2.9. Extraction of quantitative parameters
Quantiﬁcation was then performed concerning the diﬀerent phases
by using the implementation of the 3D mean intercept length (MIL)
method described in detail elsewhere [9,10]. The diﬀerent volumes were
computed by counting the number of pixels labeled by the algorithm
that automatically separates the diﬀerent phases. The 3D MIL method
was used, assuming a parallel plate model, in order to derive the vol-
ume of the injected cells.3. Results
3.1. Labeling of CD133+ cells with Endorem
Human mononucleated cells obtained from peripheral blood
were sorted for the expression of CD133 antigen (a marker
used to isolate human stem cells [1,7,8,11]). The purity of selec-
tion was 98 ± 1%. In vitro experiments conﬁrmed our previous
results [1] showing that circulating CD133+ cells have self-re-
newal capacity and possess myogenic, hematopoietic, and
endothelial potential given the right environmental cues (data
not shown). The human stem cells isolated from peripheral
blood for the expression of CD133 were labeled with iron-
oxide nanoparticles (FeO) (Endorem). Cells were visualized
as blue spots after Prussian blue staining [6] and their counting
revealed that after 12 h of labeling with Endorem the percent-
age of labeled cells was 44.2 ± 7.4% and after 24 h of labeling
the percentage was increased at 85.6 ± 8.3%. Further labeling
times did not increase either the number of labeled cells or
the number of iron oxide particles inside the cells. Next, we
investigated whether the labeling aﬀects cell viability or func-
tion. Up to 120 h after labeling with iron-oxide nanoparticles,
Trypan Blue uptake in the labeled CD133+ stem cells was not
signiﬁcantly diﬀerent from controls, with 96.1 ± 2.1% of Try-
pan Blue negative cells after labeling (n = 6). The viability of
labeled CD133+ cells was also conﬁrmed by ﬂow cytometry
analysis. In fact the annexin V and PI staining showed a vital-
ity of 96 ± 2% (Fig. 1A). The staining performed by Prussian
blue and the transmission electron microscopy (TEM) con-
ﬁrmed the presence of iron-oxide particles inside the cell, ob-
served as endoplasmatic reticulum membrane-bound clusters
within the cell cytoplasm (data not shown). Vesicles containing
Fe particles surrounded by a membrane indicated an endocy-
totic process of Fe uptake (data not shown). The Fe particles
were found in samples incubated for 48–72 h; 24 h of incuba-
tion did not result in suﬃcient incorporation of iron into all
of the cells (data not shown).
Fig. 1. The viability of labeled cells is shown in (A). The ﬂow cytometry analysis with PI and annexin V conﬁrmed the 96% viability of the Endorem
labeled cells (A). Several areas of hypointense signal were seen 12 h after intra-arterial injection of 500 · 103 stem cells by MR image (white quadrant
in B, scale bar = 1 cm). The 3D representation of the muscle biopsy obtained from the muscle region indicated by the white quadrant in B is shown in
C (scale bar = 700 lm). The conversion of the grey levels into colours led us to obtain a representation of all the structure present in the biopsy:
muscle in blue, vessels in green, labeled cells in red (C). The histology performed on the muscle biopsy analyzed by the microCT (C) conﬁrmed
positive Prussian blue cells which co-expressed the CD133 antigen (D, scale bar = 50 lm).
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To track the fate of implanted cells using a non-invasive
method we labeled CD133+ cells with Endorem and visual-
ized them by MRI. Previous in vitro results demonstrated that
iron incorporation into CD133+ stem cells can be visualized by
MRI [12]. In studies of lymphocytes migration, diapedesis
through the vessels is described as a very rapid event [13,14].
Moreover, the selected times to harvest and characterize the
intra-arterial injected animals were determined by several rig-
orous intravital microscopy experiments, which clearly demon-
strated that CD133+ cells interact with endothelial structures
within the ﬁrst hour after transplantation, leading to their
migration within 24 h [1,12]. At 12 h after intra-arterial trans-
plantation, we observed a hypointense signal obtained by MRI
evaluation in the quadriceps, tibialis anterior and soleus mus-
cle tissues (Fig. 1B) whereas no recognizable hypointense sig-
nal was detected in the muscle of the uninjected leg (data not
shown). The hypointense signal in muscle remained visible
during the ﬁrst 24 h after intra-arterial injection with no
change in shape. The microCT analysis of muscle biopsies ob-
tained from these muscles allowed us to obtain a 3D represen-
tation of the distribution of the injected cells (Fig. 1C). The
histology of these hypointense areas showed that a large num-
ber of Prussian blue-positive cells had entered into the muscle
and that most of them co-expressed the CD133 antigen around
vessels, suggesting migration from the arterial circulation
(Fig. 1D).3.3. MicroCT analysis
The Micro-CT analysis was used to non-destructively image
and characterize the 3D distribution of human CD133+ stem
cells after their intra-arterial delivery. The muscle samples were
scanned and slice data were obtained by the system and recon-
structed into 2D images (Fig. 2A). The diﬀerences in the
absorption rate of X-ray within the samples give rise to diﬀer-
ent peaks in the grey level scale corresponding to the diﬀerent
phases (Fig. 2B). The X-ray absorption of the Endorem-po-
sitive stem cells was higher than the other tissues of injected
legs, allowing their visualization as bright spots in the 2D
images (Fig. 2A). These slice images were compiled and ana-
lyzed to render 3D images and to obtain a better visualization
of the stem cell distribution after their blood delivery. Regions
of interest were selected in each slice image and thresholded to
eliminate background noise. The thresholded 3D volumes were
converted into coloured images using the 3D display software
without decomposing the samples into geometric primitives
(Fig. 2B). Using this software it is possible to correlate the
white spots of labeled cells present in the 2D images
(Fig. 2A) with the red spots distributed in the 3D reconstruc-
tion (Fig. 2C and D). Furthermore, it is possible to use the
3D image processing to make one or more phases translucent
or even to ‘‘cancel’’ a phase in order to allow a more accurate
observation of the spatial distribution of each phase. In fact,
the basic physical parameter quantiﬁed in each pixel of a
microCT-image is the linear attenuation coeﬃcient l. The
Fig. 2. Visualization of a 2D extracted tomographic slice in the Z-direction showed a cluster of Endorem labeled cells in the muscle (A, scale
bar = 300 lm). The injected stem cells are located within the muscle and are represented by the bright spots (white arrows). In B, we show an example
of the grey level histogram of the whole reconstructed volume, in which four peaks correspond to the diﬀerent phases. C and D represent the three-
dimensional visualization of the injected stem cells labeled with iron oxide nanoparticles 24 h after their intra-arterial transplantation into dystrophic
mice. The diﬀerent phases shown in B were coloured using 3D display software in order to make them more easily recognizable (see Section 2). The
labeled injected cells are visualized in red, vessels in green, and ﬁbrosis in blue. When data are elaborated in this way we obtain a correspondence
between white spots observed in 2D images (A) and the red spots distributed in the 3D reconstruction (C).
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between the grey level peak area for this phase and the total
number of voxels.
We also evaluated the minimum number of cells that could
be detected by microCT technique. We thus analyzed nine
muscular biopsies transplanted with three diﬀerent numbers
of stem cells labeled with iron-oxide nanoparticles, at three dif-
ferent times after injection. No diﬀerence in the location of
stem cells was observed at diﬀerent time points after injection,
in which human stem cells appeared distributed along the ves-
sels (not shown). The microCT signal was clear at all concen-
trations grater than 50000 cells (Fig. 3A–C). The percentage of
migrated labeled stem cells was calculated by counting their
corresponding pixels, using the algorithm that automatically
separates them from the other tissues. The obtained data were
expressed as percentage of the analyzed sample volume (2 mm/
2 mm/2 mm) and were 0.01 ± 0.005%, 0.035 ± 0.015% and
0.085 ± 0.01%, respectively in muscles injected with 50000,
100000 and 500000 cells (Fig. 3D). No detectable cells were
found in muscles injected intra-arterially with unlabeled
CD133+ cells (data not shown). To make sure that accumula-
tion of Endorem reﬂects recruitment of CD133+ cells, we in-
jected Endorem labeled human ﬁbroblast cells (n = 5) and
FeO nanoparticles without cells (n = 4). In these experiments,
we observed a marked reduction of the Endorem-labeledﬁbroblasts in the muscle of dystrophic mice, and essentially
no FeO nanoparticles were observed within the skeletal muscle
after intra-arterial injection (data not shown).4. Discussion
This investigation was carried out in the frame of a more
general research program aiming to use human stem cells to re-
pair muscle damage in Duchenne muscular dystrophy. Re-
cently we showed that, after intra-arterial delivery to murine
dystrophic muscle, human blood-derived CD133+ cells local-
ize under the basal lamina and express the satellite cells mark-
ers M-cadherin and Myf5, and diﬀerentiate into human muscle
ﬁbers [1,12] causing a signiﬁcant amelioration of skeletal mus-
cle structure. The elucidation of the mechanisms involved in
muscle homing of stem cells will aid in improving a potential
therapy for muscular dystrophy based on the systemic delivery
of such stem cells.
Magnetic nanoparticles labeling is a promising approach to
visualize stem cells in vivo, and thus will help the understand-
ing of the basic processes involved in the stem cell homing and
migration [15,16]. Combining the nanoparticles cell labeling
and the X-ray computed microtomography (microCT), it is
possible to provide detailed information on the stem cell
Fig. 3. At 12 h after the transplantation of human labeled stem cells, we visualized the three-dimensional distribution of migrating cells (in red)
within the muscle biopsies of TA muscles which received 50 (A), 100 (B) and 500 (C) · 103 labeled stem cell. In order to obtain quantitative data, the
ratio of the number of voxels and X-ray absorption coeﬃcient obtained from 256 images was produced in histograms. In D the histogram shows the
volume distribution of nanoparticles at 12 h after injection of the indicated numbers of stem cells. Scale bars in A–C correspond to 700 lm. Error
bars in D represents standard deviation (Mean ± S.D.).
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ods based on 2D techniques such as histology, scanning elec-
tron and ﬂuorescence microscopy imaging. The microCT is a
non-invasive technique giving integral information about the
content of magnetic material along the beam direction as well
as a relative local snapshot of the magnetic nanoparticle distri-
bution in relation to the number of slices [17]. In contrast to
the low spatial resolution of the MR microscopy (about
100 lm) which is not enough to examine morphology at least
on the cellular level [18], microCT provides high spatial resolu-
tion images (from 10 lm to 1 lm) with high signal-to-noise ra-
tio [9,10]. We thus used high resolution microCT scanning to
investigate the 3D distribution of stem cells labeled with mag-
netic nanoparticles in murine dystrophic muscles and delivered
systemically. In this sense human blood-derived CD133+ cells
[1,7,8,11] were labeled by iron-oxide nanoparticles (FeO) (End-
orem) and injected into the femoral artery of dystrophic scid/
mdx mice. Our in vitro results did not show any impairment of
the cell biology as a result of the labeling process. The 3D dis-
tribution of labeled cells was revealed by microCT because of a
high X-ray absorption coeﬃcient of the nanoparticles in com-
parison with the other tissues. As shown by our data, the la-
beled CD133+ stem cells were distributed around the vessels
of muscle tissues within 24 h of their intra-arterial transplanta-
tion. By contrast, we did not ﬁnd labeled human ﬁbroblast
cells or iron-oxide nanoparticles within muscle tissues after
the same intra-arterial treatment, suggesting that microCT spe-ciﬁcally recognize migrating labeled cells. We also investigated
the sensitivity of the microCT technique in stem cell tracking,
and analyzed muscle tissues injected with diﬀerent numbers of
labeled stem cells at diﬀerent times after transplantation. The
diﬀerent timing investigated did not show diﬀerences in the
location of stem cells, while the variation in stem cells number
allowed us to optimize the experimental conditions and iden-
tify 50000 as the minimum number of detectable cells a murine
muscle. Further follow-up studies are warranted to investigate
the long-term pharmacokinetics of the iron oxide particles
phagocytosed by neighbouring cells after the death of the
transplanted labeled cells, which would be expected to parallel
the well-documented pharmacokinetics of the same iron oxide
compounds after intravenous administration [19]. A crucial
goal in the development of new stem cell treatments is to
achieve and prove the homing of the transplanted cells to the
tissue where they should exert their therapeutic activity. This
is of special importance if the cells are administered systemi-
cally (e.g., after intra-venous or intra-arterial injections) rather
than directly into the target tissue. Data in our study showed
that the distribution of intra-arterially administered CD133+
stem cells within muscle biopsies can be visualized with mi-
croCT, providing biological insights into the early processes
of muscle stem cell homing. This is also potentially interesting
for future research on determining the fate of transplanted
stem cells in vivo. In fact, the microCT imaging could be ap-
plied on investigations of the homing speciﬁcity of various
5764 Y. Torrente et al. / FEBS Letters 580 (2006) 5759–5764stem cell subtypes or genetically engineered stem cells in diﬀer-
ent cell-based therapies, such as in injured myocardium, brain
and tumors. Finally, this method not only may be applicable
to monitoring the stem cell homing, but may also be used diag-
nostically in combination of MRI in order to speciﬁcally detect
and characterize inﬂammatory tissue with improved anatomic
resolution. Further studies are necessary to improve this meth-
od for future applications in the human tissues.
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